
Pilot Medical Group
Pilot Medical Group operates an integrated healthcare platform combining a licensed preventive and longevity medicine clinic with an innovation arm that validates and deploys emerging medical technologies. The company uses AI-driven health assessment tools and advanced diagnostics to enable earlier disease detection and personalized care pathways, while offering structured pilot programs for healthcare technology companies seeking clinical validation and entry into the ASEAN market.
- Healthcare Technology
- Artificial Intelligence
- Digital Health
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Healthcare systems worldwide face a widening gap between rapid medical technology advancement and slow, fragmented pathways to real patient care. Traditional medicine remains largely reactive, treating diseases after they appear rather than addressing root causes proactively, which is especially problematic for aging populations.
Solution
Pilot Medical Group operates an integrated ecosystem that bridges clinical care, healthcare technology validation, and innovation deployment. The platform combines a Ministry of Health–licensed medical clinic focused on preventive medicine, longevity healthcare, and advanced diagnostics, with an innovation integration arm that identifies, evaluates, and deploys emerging medical technologies. The company introduces AI-enabled health assessment tools that identify high-risk individuals and guide targeted screening, supported by next-generation medical-grade diagnostics. Innovations are introduced under physician supervision with strong clinical governance, regulatory awareness, and transparency to patients. The platform collaborates with universities, research institutions, and healthcare technology companies across North America, Europe, and Asia to provide structured pilot programs and a pathway into the ASEAN healthcare market.
Target Audience
Primary customers include healthcare technology innovators and startups seeking clinical validation and market entry pathways, as well as healthcare organizations and private clinics looking to adopt AI and emerging medical technologies.
Features
- AI-driven health assessment tools that analyze vast datasets to detect subtle patterns for earlier detection of cardiovascular disease or cancer risks
- Medical-grade diagnostics combined with proactive longevity medicine protocols addressing root causes of aging at a cellular level
- Clinical incubation sandbox for testing advanced AI-driven screenings and regenerative protocols in real-world practice
- Structured pilot programs providing access to a regulated clinical setting for real-world validation of emerging healthcare technologies
- Regulatory navigation support for healthcare technology companies entering Asian markets
- Clear disclosures and informed consent protocols distinguishing medical services from non-classified digital health tools